07:40 AM EDT, 03/11/2026 (MT Newswires) -- Redwire ( RDW ) said Wednesday it has received additional funding of $4 million from National Aeronautics and Space Administration to support new drug development research on the International Space Station.
The funding expands an existing task order under a $25 million, five-year indefinite-delivery, indefinite-quantity contract award, the company said.